Co-founder & CEO, Lobo Genetics
John is the co-founder and CEO of Lobo and brings 15 years experience in life sciences, medical devices and capital markets. Prior to Lobo, he was the co-founder and VP of Corporate Development of Spartan Bioscience. Previously, John worked at Waterfall Investments, a Toronto-based hedge fund, where he specialized in Canadian and US healthcare investments. Waterfall was acquired by Sentry Investments, a $19-billion asset management company. John holds a BASc in computer engineering from the Engineering Science program at the University of Toronto.